Inaba, Yoshitaka http://orcid.org/0000-0002-0850-6327
Chatani, Shohei
Murata, Shinichi
Sato, Yozo
Imamine, Rinpei
Kato, Mina
Onaya, Hiroaki
Yamaura, Hidekazu
Article History
Received: 13 November 2023
Accepted: 6 January 2024
First Online: 11 February 2024
Declarations
:
: Y. Inaba received contract research funds for clinical trials from Eisai, Chugai Pharmaceutical, and AstraZeneca. Other authors declare that they have no conflict of interest.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008(5).
: Informed consent waived for this case report.